Structures by: Lowary T. L.
Total: 18
C38H32N4O19
C38H32N4O19
Organic letters (2011) 13, 19 5290-5293
a=21.7700(7)Å b=12.9719(4)Å c=14.4182(5)Å
α=90.00° β=94.7022(4)° γ=90.00°
{1-(Cyclohexyloxy)-1,3,3a,9a-tetrahydrofuro[3,4-b][1,4]benzodioxin-1- yl}methanol
C19H26O5
Organic & biomolecular chemistry (2020) 18, 12 2264-2273
a=5.3125(2)Å b=12.3867(5)Å c=13.7161(6)Å
α=90° β=90.529(3)° γ=90°
C11H12N4O7S
C11H12N4O7S
MedChemComm (2014) 5, 8 1130
a=6.0562(5)Å b=8.3474(7)Å c=14.3363(12)Å
α=80.2127(11)° β=88.9452(11)° γ=84.4944(11)°
\ <i>p</i>-Tolyl \ 3-amino-3-<i>N</i>,4-<i>O</i>-carbonyl-2,3,6-trideoxy-\ 1-thio-α-L-<i>lyxo</i>-hexopyranoside
C14H17NO3S
Acta Crystallographica Section E (2006) 62, 7 o2788-o2790
a=5.9331(6)Å b=6.0141(6)Å c=38.941(4)Å
α=90° β=90° γ=90°
Methyl 3-amino-3-N,4-O-carbonyl-2,3,6-trideoxy-α-L-lyxo-hexopyranoside
C8H13NO4
Acta Crystallographica Section E (2006) 62, 6 o2490-o2492
a=5.2411(8)Å b=10.2928(16)Å c=16.760(3)Å
α=90.00° β=90.00° γ=90.00°
(3S,1S)-1-tert-Butyldiphenylsiloxy-3-hydroxy-3-isopropenyl-1,2,3,4- tetrahydronaphthalene
C29H34O2Si
Acta Crystallographica Section E (2005) 61, 12 o4295-o4297
a=10.4483(12)Å b=10.2152(12)Å c=11.6877(13)Å
α=90.00° β=94.506(2)° γ=90.00°
Methyl 2,3-amino-3-N,4-O-carbonyl-2,3-N-cyclo-2,3,6-trideoxy-α-L-allopyranoside
C8H11NO4
Acta Crystallographica Section E (2006) 62, 7 o2573-o2575
a=5.7376(6)Å b=9.3890(9)Å c=16.2562(16)Å
α=90.00° β=90.00° γ=90.00°
Methyl 2,3-amino-3-N,4-O-carbonyl-2,3-N-cyclo-2,3,6-trideoxy-α-L- allopyranoside
C8H11NO4
Acta Crystallographica Section E (2006) 62, 7 o2576-o2577
a=6.3749(5)Å b=9.9173(7)Å c=13.6010(10)Å
α=90.00° β=90.00° γ=90.00°
5,6,7,9-Tetra-O-acetyl-4,8-anhydro-1,2,3-trideoxy-D-glycero-D-gulo- non-1-enitol
C17H24O9
Acta Crystallographica Section E (2004) 60, 11 o1939-o1941
a=5.4608(6)Å b=14.4068(17)Å c=24.392(3)Å
α=90.00° β=90.00° γ=90.00°
4,8-anhydro-1,2,3,5-tetradeoxy-D-allo-non-1-enitol
C9H16O4
Acta Crystallographica Section E (2004) 60, 11 o1942-o1944
a=13.3072(14)Å b=13.3072(14)Å c=5.1172(11)Å
α=90.00° β=90.00° γ=120.00°
1-(2,3'-Anhydro-5'-O-benzoyl-β-D-lyxofuranoyl)-5-fluorouracil
C16H13FN2O6
Acta Crystallographica Section E (2003) 59, 7 o1063-o1065
a=7.3537(8)Å b=5.5149(8)Å c=19.290(2)Å
α=90.00° β=100.928(9)° γ=90.00°
P-tolyl 2,3-anhydro-5,6-O-isopropylidene-1-thio-β-D-talofuranoside
C16H20O4S
Acta Crystallographica Section E (2004) 60, 12 o2201-o2203
a=9.1248(7)Å b=12.0366(10)Å c=14.2666(11)Å
α=90.00° β=90.00° γ=90.00°
P-Tolyl 2-O-benzyl-3,5-O-(di-tert-butylsilanediyl)-1-thio-α-D-arabinofuranoside
C27H38O4SSi
Acta Crystallographica Section E (2007) 63, 2 o498-o500
a=14.2256(15)Å b=6.4531(7)Å c=15.0426(16)Å
α=90.00° β=101.8651(14)° γ=90.00°
2-(Methoxymethoxy)-1-(4-oxobicyclo[3.1.0]hexan-1-yl)ethyl 4-nitrobenzoate
C17H19NO7
Acta Crystallographica Section E (2008) 64, 1 o329-o329
a=8.3387(5)Å b=10.1389(6)Å c=10.4935(6)Å
α=98.5259(8)° β=100.4967(8)° γ=101.1562(7)°
(1R,2R,3R,4R,5S)-2,3-Bis[(2S')-2-acetoxy-2-phenylacetoxy]-4-azido-1-[(2,4- dinitrophenyl)hydrazonomethyl]bicyclo[3.1.0]hexane
C33H29N7O12
Acta Crystallographica Section E (2008) 64, 2 o459-o460
a=6.8522(11)Å b=17.747(3)Å c=13.729(2)Å
α=90.00° β=99.006(2)° γ=90.00°
P-Cresyl 2,3-anhydro-5-phthalimido-1-thio-α-D-lyxofuranoside
C20H17NO4S
Acta Crystallographica Section C (2000) 56, 8 e365-e365
a=12.1660(4)Å b=5.5725(2)Å c=14.5413(4)Å
α=90.00° β=109.247(2)° γ=90.00°
C22H24O7
C22H24O7
The Journal of organic chemistry (2019) 84, 1 14-41
a=6.0738(5)Å b=31.982(2)Å c=10.2483(8)Å
α=90° β=102.879(5)° γ=90°
C25H28O9,CH2Cl2
C25H28O9,CH2Cl2
The Journal of organic chemistry (2019) 84, 1 14-41
a=5.68560(10)Å b=15.7385(3)Å c=29.0307(5)Å
α=90° β=94.9272(9)° γ=90°